This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Prexige

Novartis AG

Drug Names(s): Lumiracoxib, COX189, Joicela (EU)

Description: Prexige is in the class of drugs known as COX-2 inhibitors, the same class as Celebrex, Vioxx, and Bextra. Prexige is structurally distinct and most selective COX-2 inhibitor. COX-2 inhibitors are non-steroidal anti-inflammatory drugs. Because drugs in this class selectively inhibit COX-2, side effects in the stomach and intestine are reduced.


Prexige News

Pink Sheet Drug Safety

Pink Sheet Drug Safety


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug